title: Paliperidone palmitate use in pregnancy in a woman with schizophrenia.
abstract: Long-acting antipsychotic use in schizophrenia has become an advantage for treatment compliance and convenient administration of the drugs. There is no data on paliperidone palmitate (PP) use in pregnancy, which is the longest-acting (i.e., 1 month) atypical antipsychotic. In this case report, we aim to present a patient diagnosed with schizophrenia who had been using PP before and during her pregnancy until week 28 of gestation and gave birth to a male baby that weighed 3000 g at 39 weeks. As far as we know, this is the first case report on PP use during pregnancy.
authors.affiliation: Department of Psychiatry, Akdeniz University School of Medicine, Kampüs, 07059, Antalya, Turkey.
authors.forename: Aslı Karadağ
authors.initials: AK
authors.lastname: Özdemir
authors.forename: Şima Ceren
authors.initials: ŞC
authors.lastname: Pak
authors.forename: Fatih
authors.initials: F
authors.lastname: Canan
authors.forename: Ömer
authors.initials: Ö
authors.lastname: Geçici
authors.forename: Murat
authors.initials: M
authors.lastname: Kuloğlu
authors.forename: Mustafa Kadri
authors.initials: MK
authors.lastname: Gücer
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D000068882:Paliperidone Palmitate / Q000008:administration & dosage* / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000523:psychology; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D000068882:Paliperidone Palmitate